Crossmark

Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)—a study of 1084 patients

Crossref DOI link: https://doi.org/10.1038/s41375-019-0690-7

Published Online: 2019-12-13

Published Print: 2020-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Coltro, Giacomo

Mangaonkar, Abhishek A.

Lasho, Terra L.

Finke, Christy M.

Pophali, Prateek

Carr, Ryan

Gangat, Naseema

Binder, Moritz http://orcid.org/0000-0001-9014-9658
Pardanani, Animesh

Fernandez-Zapico, Martin

Robertson, Keith D.

Bosi, Alberto

Droin, Nathalie

Vannucchi, Alessandro M. http://orcid.org/0000-0001-5755-0730
Tefferi, Ayalew

Hunter, Anthony

Padron, Eric

Solary, Eric

Patnaik, Mrinal M. http://orcid.org/0000-0001-6998-662X
Funding

Funding for this research was provided by:

Associazione Italiana per la Ricerca sul Cancro (21267, 21267)

Institut National Du Cancer (TRANSLA13-157, PRT-K16-057, PRT-K16-067, TRANSLA13-157, PRT-K16-057, PRT-K16-067)

Ligue Nationale Contre le Cancer

Accelerator Award from CR, UK
License Information

Text and Data Mining valid from 2019-12-13

Version of Record valid from 2019-12-13
More Information

Article History

Received: 16 September 2019

Revised: 18 November 2019

Accepted: 5 December 2019

First Online: 13 December 2019

Compliance with ethical standards

:

: MMP: advisory board for Stem Line Pharmaceuticals. The other authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below